Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.5 CNY 0.66% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zhejiang Shouxiangu Pharmaceutical Co Ltd

Current Assets 1.7B
Cash & Short-Term Investments 1.2B
Receivables 138.3m
Other Current Assets 411.5m
Non-Current Assets 1.4B
Long-Term Investments 299.3m
PP&E 926.6m
Intangibles 89.3m
Other Non-Current Assets 70.2m
Current Liabilities 465.6m
Accounts Payable 167.8m
Accrued Liabilities 29.3m
Short-Term Debt 243.6m
Other Current Liabilities 24.8m
Non-Current Liabilities 433.4m
Long-Term Debt 378m
Other Non-Current Liabilities 55.3m

Balance Sheet
Zhejiang Shouxiangu Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
41
18
5
89
166
206
669
678
1 270
1 504
Cash
0
0
0
0
0
0
0
678
1 270
1 504
Cash Equivalents
41
18
5
89
166
206
669
0
0
0
Short-Term Investments
0
16
11
218
166
199
50
130
30
0
Total Receivables
40
41
44
48
74
76
88
128
146
124
Accounts Receivables
37
38
38
37
63
63
70
85
114
91
Other Receivables
3
2
6
11
10
13
18
43
32
33
Inventory
59
79
101
113
119
110
99
99
148
158
Other Current Assets
4
6
6
15
8
13
16
11
269
949
Total Current Assets
143
159
167
484
532
603
923
1 045
1 862
1 807
PP&E Net
189
247
236
177
275
313
375
523
605
687
PP&E Gross
189
247
236
177
275
313
375
523
605
687
Accumulated Depreciation
39
53
73
78
87
105
124
156
199
240
Intangible Assets
4
62
77
78
74
81
79
83
78
311
Long-Term Investments
21
114
111
170
288
314
295
271
258
289
Other Long-Term Assets
144
25
22
18
22
31
29
40
53
80
Total Assets
501
N/A
606
+21%
612
+1%
926
+51%
1 192
+29%
1 341
+13%
1 700
+27%
1 962
+15%
2 856
+46%
3 174
+11%
Liabilities
Accounts Payable
45
39
20
23
35
26
90
141
144
146
Accrued Liabilities
16
14
18
18
27
28
29
33
41
42
Short-Term Debt
104
168
123
0
41
11
1
0
273
370
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
6
5
12
Other Current Liabilities
7
6
4
8
94
81
44
20
15
16
Total Current Liabilities
172
226
165
48
196
147
165
199
478
585
Long-Term Debt
0
0
0
0
0
0
188
101
429
364
Deferred Income Tax
0
0
0
0
0
5
4
4
3
4
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
9
12
10
9
11
17
16
38
41
50
Total Liabilities
180
N/A
237
+32%
175
-26%
57
-68%
207
+265%
168
-19%
373
+122%
343
-8%
951
+177%
1 003
+6%
Equity
Common Stock
105
105
105
140
143
144
148
152
197
202
Retained Earnings
75
123
192
264
343
434
536
691
908
1 076
Additional Paid In Capital
140
140
140
466
583
634
769
900
856
966
Treasury Stock
0
0
0
0
85
69
194
165
165
165
Other Equity
0
0
0
0
0
30
68
41
109
93
Total Equity
321
N/A
369
+15%
437
+19%
870
+99%
985
+13%
1 173
+19%
1 326
+13%
1 620
+22%
1 906
+18%
2 171
+14%
Total Liabilities & Equity
501
N/A
606
+21%
612
+1%
926
+51%
1 192
+29%
1 341
+13%
1 700
+27%
1 962
+15%
2 856
+46%
3 174
+11%
Shares Outstanding
Common Shares Outstanding
105
105
105
140
140
140
143
193
192
197

See Also

Discover More